Abstract
Efficacy and Safety of 0.15% Isobutylamido Thiazolyl Resorcinol Combined with Hyaluronic Acid Vs 0.15% Isobutylamido Thiazolyl Resorcinol or Hyaluronic Acid Alone in Melasma Treatment: a Randomized Evaluator-Blind Trial
This is a members-only content. Please log in to access it.